Small-molecule inhibitors of fibroblast growth factor receptor (FGFR) tyrosine kinases (TK)

Current Pharmaceutical Design

Volumn 9, Issue 7, 2003, Pages 567-581

  Manetti, Fabrizio ^a   Botta, Maurizio ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 TERT BUTYL 3 [6 (3,5 DIMETHOXYPHENYL) 2 (4 DIETHYLAMINOBUTYLAMINO)PYRIDO[2,3 D]PYRIMIDIN 7 YL]UREA; 2 AMINO 7 (3 TERT BUTYLUREIDO) 6 (2,6 DICHLOROPHENYL)PYRIDO[2,3 D]PYRIMIDINE; 2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; 3 [4 (1 FORMYLPIPERAZIN 4 YL)BENZYLIDENYL] 2 INDOLINONE; 3 [4 METHYL 2 (2 OXO 3 INDOLINYLMETHYLIDENYL) 3 PYRROLYL]PROPIONIC ACID; 3 [[3 (2 CARBOXYETHYL) 4 METHYLPYRROL 2 YL]METHYLENE] 2 INDOLINONE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; DISULFOGLUCOSAMINE; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR BLOCKING AGENT; GLUCOSAMINE DERIVATIVE; HEPARAN SULFATE; IDURONIC ACID; IDURONIC ACID DERIVATIVE; INDOLE DERIVATIVE; N (4 BROMO 2 FLUOROPHENYL) 6 METHOXY 7 [2 (1H 1,2,3 TRIAZOL 1 YL)ETHOXY] 4 QUINAZOLINAMINE; PD 145709; PD 161570; PD 166285; PD 166866; PD 173074; POLYPEPTIDE; PROTEIN TYROSINE KINASE INHIBITOR; PROTEOGLYCAN; RECEPTOR BLOCKING AGENT; SEMAXANIB; SU 4984; SULFOGLUCURONIC ACID; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER INHIBITION; CELL DIFFERENTIATION; CELL MATURATION; CELL TYPE; CLINICAL TRIAL; COMPLEX FORMATION; DRUG DESIGN; DRUG SOLUBILITY; DRUG STRUCTURE; EMBRYO DEVELOPMENT; HUMAN; MITOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN SYNTHESIS; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TISSUE; TUMOR VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN-TYROSINE KINASES; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037279999     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612033391487     Document Type: Review

References (112)

1. Risau, W.; Flamme, I. Annu. Rev. Cell. Dev. Biol., 1995, 11, 73.
2. Folkman, J. New. Engl. J. Med., 1995, 333, 1757.
3. Klagsbrun, M.; D'Amore, P. A. Annu. Rev. Physiol., 1991, 53, 17.
4. Gerwins, P.; Skoldenberg, E.; Claesson-Welsh, L. Crit. Rev. Oncol. Hematol., 2000, 34, 185.
5. Fu, X.; Shen, Z.; Chen. Y.; Xie, J.; Guo, Z.; Zhang, M.; Sheng, Z. Lancet, 1998, 352, 1661.
6. Giatromanolaki, A., Sivridis, E., Athanassou, N., Zois, E., Thorpe, P. E., Brekken. R. A., Gatter, K. C., Harris, A. L., Koukourakis, I. M., Koukourakis, M. I. J. Path., 2001, 194, 101.
7. Adamis, A. P., Shima, D. T., Yeo, K. T., Yeo, T. K., Brown, L. F., Berse, B., D'Amore, P. A., Folkman, J. Biochem. Biophys. Res. Commun., 1993, 193, 631.
8. Detmar, M. Dermatol. Sci., 2000, 24, S78.
9. Splawinski, J. Drugs Today, 1988, 24, 821.
10. Folkman, J.; Merler, E.; Abernathy, C.; Williams, G. J. Exp. Med., 1971, 133, 275.
11. Folkman, J.; Klagsbrun, M. Nature, 1987, 329, 671.
12. Folkman, J. J. Natl. Cancer Inst., 1990, 82, 4.
13. Weidner, N.; Semple, J. P.; Welch, W. R.; Folkman, J. N. Engl. J. Med., 1991, 324, 1.
14. Aaronson, S. Science, 1991, 254, 1146.
15. Miller, T. A.; Bulman, A. L.; Thompson, C. D.; Garst, M. E.; MacDonald. T. L. Bioorg. Med. Chem. Lett., 1997, 7, 1851.
16. The antiangiogenic therapy self-help book for cancer patients. Angiogenesis foundation, Inc.: Cambridge, MA, 1999.
17. Folkman, J. New. Engl. J. Med., 1971, 285, 1182.
18. Folkman, J. Ann. Surg., 1972, 175, 409.
19. Gasparini, G. Drugs, 1999, 58, 17.
20. Gourley, M.; Williamson, J.S. Curr. Pharm. Des., 2000, 6, 417.
21. Brem, S. Cancer Control, 1999, 6, 436.
22. Folkman, J.; Klagsbrun, M. Science, 1987, 235, 442.
23. Hayek, A.; Culler, F. L.; Beattie, G. M.; Lopez, A. D.; Cuevas, P.; Baird, A. Biochem. Biophys. Res. Commun., 1987, 147, 876.
24. Hori, A.; Sasada, R.; Matsutani, E.; Naito, K.; Sakura, Y.; Fujita, T.; Kozai, Y. Cancer Res., 1991, 51, 6180.
25. Takahashi, J.A.; Fukutomoto, M.; Kozai, Y.; Ito, N.; Oda. Y.; Kikuchi, H.; Hatanaka, M. FEBS Lett., 1991, 288, 65.
26. Manetti, F., Corelli, F., Botta, M. Curr. Pharm. Des., 2000, 6, 1897.
27. Kirikoshi, H., Sagara, N., Saitoh, T., Tanaka. K., Sekihara, H., Shiokawa, K., Katoh, M. Biochem. Biophys. Res. Commun., 2000, 274, 337.
28. Nishimura, T., Nakatake, Y., Konishi, M., Itoh, N. Biochim. Biophys. Acta, 2000, 1492, 203.
29. Nakatake, Y., Hoshikawa, M., Asaki, T., Kassai, Y., Itoh, N. Biochim. Biophys. Acta, 2001, 1517, 460.
30. Yamashita, T., Yoshioka, M., Itoh, N. Biochem. Biophys. Res. Commun., 2000, 277, 494.
31. Shawver, L. K. Tyrosine kinase inhibitors: from the emergence of targets to their clinical development. In: American Society of Clinical Oncology Education Book; Perry, M. C.; Ed.; 1999, pp. 29-47.
32. Garcia-Echeverria, C., Traxler, P., Evans, D. B. Med. Res. Rev., 2000, 20, 28.
33. Fantl, W. J., Rosenberg, S. Anti-angiogenesis as a therapeutic strategy for cancer. In: Annual reports in medicinal chemistry. Plattner J. J.; Ed.; Academic Press: New York, 2000, pp. 123-133.
34. McIntosh, I., Bellus, G. A., Jabs, E. W. Cell Struct. Funct., 2000, 25, 85.
35. Showalter, H. D. H., Kraker, A. J. Pharmacol. Ther., 1997, 76, 55.
36. Goel, S., Mani, S., Perez-Soler, R. Curr. Oncol. Rep., 2002, 4, 9.
37. Haluska, P., Adjei, A. A. Curr. Opin. Investig. Drugs, 2001, 2, 280.
38. Hamby, J. M., Showalter, H. D. H. Pharmacol. Ther., 1999, 82, 169.
39. Sun, L., McMahon, G. Drug Discov. Today, 2000, 5, 344.
40. Levitt, M. L., Koty, P. P. Invest. New Drugs, 1999, 17, 213.
41. Bilodeau, M. T., Fraley, M. E., Hartman, G. D. Expert Opin. Investig. Drugs, 2002, 11, 737.
42. Conrad, H. E. Fibroblast growth factors. In: Heparin-Binding Proteins; Conrad, H. E.; Ed.; Academic Press: San Diego, 1998, pp. 301-349.
43. Klint, P., Claesson-Welsh, L. Front. Biosci., 1999, 4, d165.
44. Kim, I., Moon, S.-O., Yu, K.-H., Kim, U.-H, Koh, G. Y. Biochim. Biophys. Acta, 2001, 1518, 152.
45. Wiedemann, M., Trueb, B. Genomics, 2000, 69, 275.
46. Wiedemann, M., Trueb. B. Biochim. Biophys. Acta, 2001, 1520, 247.
47. Sleeman, M., Fraser, J., McDonald, M., Yuan, S, White, D., Grandison, P., Kumble, K., Watson, J. D., Murison, J. G. Gene, 2001, 271, 171.
48. Leelayuwat, C., Abraham, L. J., Pinelli, M., Townend, D. C., Wilks, A. F., Dawkins, R. L. Tissue Antigens, 1996, 48, 59.
49. Kamei, S., Yajima. I., Yamamoto, H., Kobayashi, A., Makabe, K. W., Yamazaki, H., Hayashi, S.-I., Kunisada, T. Biochem. Biophys. Res. Commun., 2000, 275, 503.
50. Shimauchi, Y., Murakami, S. D., Satoh, N. Development, 2001, 128, 2711.
51. Mohammadi, M., McMahon, G., Sun, L., Tang, C., Hirth, P., Yeh, B. K., Hubbard, S. R., Schlessinger, J. Science, 1997, 276, 955.
52. Plotnikov, A. N., Schlessinger, J., Hubbard, S. R., Mohammadi, M. Cell, 1999, 98, 641.
53. Stauber, D. J., DiGabriele, A. D., Hendrickson, W. A. Proc. Natl. Acad. Sci. USA, 2000, 97, 49.
54. Pellegrini, L., Burke, D. F., von Delft, F., Mulloy, B., Blundell, T. L. Nature, 2000, 407, 1029.
55. Plotnikov, A. N., Hubbard, S. R., Schlessinger, J., Mohammadi, M. Cell, 2000, 101, 413.
56. Mohammadi, M., Schlessinger, J., Hubbard, S. R. Cell, 1996, 86, 577.
57. Schlessinger, J., Plotnikov, A. N., Ibrahimi, O. A., Eliseenkova, A. V., Yeh, B. K., Yayon, A., Linhardt, R. J., Mohammadi, M. Mol. Cell, 2000, 6, 743.
58. Ibrahimi, O. A., Eliseenkova, A. V., Plotnikov, A. N., Yu, K., Ornitz, D. M., Mohammadi, M. Proc. Natl. Acad. Sci. USA, 2001, 98, 7182.
59. Huhtala, M. T., Pentikainen, O. T., Johnson, M. S. Structure, 1999, 7, 699.
60. Mohammadi, M., Froum, S., Hamby, J. M., Schroeder, M. C., Panek, R. L., Lu, G. H., Eliseenkova, A. V., Green, D., Schlessinger, J., Hubbard, S. R. EMBO J., 1998, 17, 5896.
61. Zhou, F. Y., Kan, M., Ownes, R. T., McKeehan, W. L., Thompson,. J. A., Linhardt, R. J., Hook, M. Eur. J. Cell. Biol., 1997, 73, 71.
62. Ornitz, D. M., Herr, A. B., Nilsson, M., Estman J., Svahn, C. M., Waksman G. Science, 1995, 268, 432.
63. An entire issue of Pharmacology & Therapeutics (namely, Pharmacol. Ther., 2002, 93, 77-329) has been very recently dedicated to the inhibitors of protein kinases.
64. Fabbro, D., Ruetz, S., Buchdunger, E., Cowan-Jacob, S. W., Fendrich, G., Liebetanz, J., Mestan, J., O'Reilly, T., Traxler, P., Chaudhuri, B., Fretz, H., Zimmermann, J., Meyer, T., Caravatti, G., Furet, P., Manley, P. W. Pharmacol. Ther., 2002, 93, 79.
65. Davies, S. P., Reddy, H., Caivano, M., Cohen P. Biochem. J., 2000, 351, 95.
66. Wilson, K. P., McCaffrey, P. G., Hsiao, K. Pazhanisamy, S., Galullo, V., Bemis, G. W., Fitsgibbon, M. J., Caron, P. R., Murcko, M. A., Su, M. S. S. Chem. Biol., 1997, 4, 423.
67. Palmer, B. D., Trumpp-Kallmeyer, S., Fry, D. W., Nelson, J. M., Showalter, H. D. H., Denny, W. A. J. Med. Chem., 1997, 40, 1519.
68. Sun, L., Tran, N., Liang, C., Tang, F., Rice, A., Schreck, R., Waltz, K., Shawver, L. K., McMahon, G., Tang, C. J. Med. Chem., 1999, 42, 5120.
69. Laird, A. D., Vajkoczy, P., Shawver, L. K., Thurnher, A., Liang, C., Mohammadi, M., Schlessinger, J., Ullrich, A., Hubbard, S. R., Blake, R. A., Fong, T. A. T., Strawn, L. M., Sun, L., Tang, C., Hawtin, R., Tang, F., Shenoy, N., Hirth, K. P., McMahon, G., Cherrington, J. M. Cancer Res., 2000, 60, 4152.
70. Shaheen, R. M., Tseng, W. W., Davis, D. W., Liu, W., Reinmuth, N., Vellagas, R., Wieczorek, A. A., Ogura, Y., McConkey, D. J., Drazan, K. E., Bucana, C. D., McMahon, G., Ellis, L. M. Cancer Res., 2001, 61, 1464.
71. Folkman, J. N. Engl. J. Med., 1995, 333, 1757.
72. Fidler, I. J., Ellis. L. M. Cell, 1994, 79, 185.
73. Hoekman, K. Cancer J., 2001, Suppl. 3, S134.
74. Rosen, L., Hannah, A., Rosen, P., Kabbinnavar, F. Proc. Am. Soc. Clin. Oncol., 2000, 19, 708.
75. Further details are available at: http://www.sugen.com/webpage_templates/home.php3.
76. Ning, S., Laird, D., Cherrington, J. M., Knox, S. J. Radiat. Res., 2002, 157, 45.
77. Browder, T., Butterfield, C. E., Kraling, B. M., Shi, B., Marshall, B., O'Reilly, M. S., Folkman, J. Cancer Res., 2000, 60, 1878.
78. Klement, G., Baruche, S., Rak, J., Man, S., Clark, K., Hicklin, D. J., Bohlen, P., Kerbel, R. S. J. Clin. Investig., 2000, 105, R15.
79. Sun, L., Tran, N., Liang, C., Hubbard, S., Tang, F., Lipson, K., Schreck, R., Zhou, Y., McMahon, G., Tang, C. J. Med. Chem., 2000, 43, 2655.
80. Sun, L., Tran, N., Tang, F., App., H., Hirth, P., McMahon, G., Tang, C. J. Med. Chem., 1998, 42, 2588.
81. Shaheen, R. M., Davis, D. W., Liu, W., Zebrowski, B. K., Wilson. M. R., Bucana, C. D., McConkey, D. J., McMahon, G., Ellis, L. M. Cancer Res., 1999, 59, 5412.
82. Mendel, D. B., Laird, A. D., Smolich, B. D., Blake, R. A., Liang, C., Hannah, A. L., Shaheen, R. M., Ellis, L. M., Weitman, S., Shawver, L. K., Cherrington, J. M. Anti-Cancer Drug Des., 2000, 15, 29.
83. Fong, T. A. T., Shawver, L. K., Sun, L., Tang, C., App, H., Powell, T. J., Kim, Y. H., Schreck, R., Wang, X., Risau, W., Ullrich, A., Hirth, K. P., McMahon, G. Cancer Res., 1999, 59, 99.
84. Blankley, C. J., Doherty, A. M., Hamby, J. M., Panek, R. L., Schroeder, M. C., Showalter. H. D. H., Connolly, C. J. C. WO PCT Appl. 9615128, 1996; Chem. Abstr. 1995, 125, 114688k.
85. Dahring, T. K., Lu, G. H., Hamby. J. M.. Batley, B. L., Kraker, A. J., Panek, R. L. J. Pharmacol. Exp. Ther., 1997., 281, 1446.
86. Connoly, C. J. C., Hamby, J. M., Schroeder, M. C., Barvian, M., Lu, G. H., Panek, R. L., Amar, A., Shen, C., Kraker, A. J., Fry, D. W., Klohs, W. D., Doherty, A. M. Bioorg. Med. Chem. Lett., 1997, 7, 2415.
87. Panek, R. L., Lu, G. H., Dahring, T. K., Batley, B. L., Connolly, C., Hamby,. J. M., Brown, K. J. J. Pharmacol. Exp. Ther., 1999, 286, 569.
88. Hamby, J. M., Connolly, C. J. C., Schroeder, M. C., Winters, R. T., Showalter, H. D. H., Panek, R. L., Major, T. C., Olsewski, B., Ryan, M. J., Dahring, T., Lu, G. H., Keiser, J., Amar, A., Shen, C., Kraker, A. J., Slintak, V., Nelson, J. M., Fry, D. W., Bradford, L., Hallak, H., Doherty, A. M. J. Med. Chem., 1997, 40, 2296.
89. Batley, B. L., Doherty, A. M., Hamby,. J. M., Lu, G. H., Keller, P., Dahring, T. K., Hwang, O., Crickard,, K., Panek, R. L. Life, Sci., 1998, 62, 143.
90. Schroeder, M. C., Hamby, J. M., Connolly, C. J. C., Grohar, P. J., Winters, R. T., Barvian, M. R., Moore, C. W., Boushelle, S. L., Crean, S. M., Kraker, A. J., Driscoll, D.L., Vincent, P. W., Elliott, W. L., Lu, G. H., Batley, B. L., Dahring, T. K., Major, T. C., Panek, R. L., Doherty, A. M., Showalter, H. D. H. J. Med. Chem., 2001, 44, 1915.
91. Hennequin, L. F., Thomas, A. P., Johnstone, C., Stokes, E. S. E., Ple, P. A., Lohmann, J.-J. M., Ogilvie, D. J., Dukes, M., Wedge, S. R., Curwen, J. O., Kendrew, J., Lambert-van der Brempt, C. J. Med. Chem., 1999, 42, 5369.
92. Hennequin, L. F., Stokes, E. S. E., Thomas, A. P., Johnstone, C., Ple, P. A., Ogilvie, D. J., Dukes, M., Wedge, S. R., Kendrew, J., Curwen, J. O. J. Med. Chem., 2002, 45, 1300.
93. Wedge, S. R., Ogilvie, D. J., Dukes, M., Kendrew, J., Curwen, J. O., Hennequin, L. F., Thomas, A. P., Stokes, E. S. E., Curry, B., Richmond, G. H. P., Wadsworth, P. F. Cancer Res., 2000, 60, 970.
94. Klutchko, S. R., Hamby, J. M., Boschelli, D. H., Wu, Z., Kraker, A. J., Amar, A. M., Hartl, B. G., Shen, C., Klohs, W. D., Steinkampf, R. W., Driscoll, D. L., Nelson, J. M., Elliott, W. L., Roberts, B. J., Stoner, C. L., Vincent, P. W., Dykes, D. J., Panek, R. L., Lu, G. H., Major, T. C., Dahring, T. K., Hallak. H., Bradford, L. A., Showalter, H. D. H., Doherty, A. D. J. Med. Chem., 1998, 41, 3276.
95. Trumpp-Kallmeyer, S., Rubin, R. J. Humblet, C., Hamby, J. M., Showalter, H. D. H. J. Med. Chem., 1998, 41, 1752.
96. Panek, R. L., Lu, G. H., Klutchko, S. R., Batley, B. L., Dahring, T. K., Hamby, J. M., Hallak, J., Doherty, A. M., Keiser, J. A. J. Pharmacol. Exp. Ther., 1997, 283, 1433.
97. Dimitroff, C. J., Klohs, W., Sharma, A., Pera, P., Driscoll, D., Veith, J., Steinkampf, R., Schroeder, M., Klutchko, S., Sumlin, A., Henderson, B., Dougherty, T.J., Bernacki, R.J. Invest. New Drugs, 1999, 17, 121-35.
98. Star, W. M., Marijinissen, H. P., van den Berg-Blok, A. E., Versteeg, J. A., Franken, K. A., Reinhold, H. S. Cancer Res., 1986, 46, 2532.
99. Reed, M. W., Schuschke, D. A., Ackermann, D. M., Harty, J. I., Wieman, T. H., Miller, F. N. J. Urol., 1989, 142, 865.
100. Henderson, B. W., Dougherty. T. J., Malone, P. B. Studies on the mechanism of tumor destruction by photodynamic therapy. In: Porphyrin localization and treatment of tumors. Doiron D. R. and Gomer C. J.; Eds.; Alan R. Liss: New York, 1984, pp. 601-612.
101. Skaper, S. D., Kee, W. J., Facci, L., Macdonald, G., Doherty, P., Walsh, F. S. J. Neurochem., 2000, 75, 1520.
102. Schulze-Gahmen, U., Brandsen, J., Jones, H. D., Morgan, D. O., Meijer, L., Vesely, J., Kim, S.-H. Proteins Struct. Funct. Genet., 1995, 22, 378.
103. Thompson, A. M., Connolly, C. J. C., Hamby, J. M., Boushelle, S., Hartl, B. G., Amar, A. M., Kraker, A. J., Driscoll, D. L., Steinkampf, R. W., Patmore, S. J., Vincent, P. W., Roberts, B. J., Elliott, W. L., Klohs, W., Leopold, W. R., Showalter, H. D. H., Denny, W. A. J. Med. Chem., 2000, 43, 4200.
104. Thompson, A. M., Rewcastle, G. W., Boushelle, S. L., Hartl, B. G., Kraker, A. J., Lu, G. H., Batley, B. L., Panek, R. L., Showalter, H. D. H., Denny, W. A. J. Med. Chem., 2000, 43, 3134.
105. Palmer, B. D., Rewcastle, G. W., Thompson, A. M., Boyd, M., Showalter, H. D. H., Sercel, A. D., Fry, D. W., Kraker, A. J., Denny, W. A. J. Med. Chem., 1995, 38, 58.
106. Rewcastle, G. W., Palmer, B. D., Fry, D. W., Kraker, A, J., Denny, W. A. J. Med. Chem., 1994, 37, 2033.
107. Fry, D. W., Nelson, J. M. Anti-Cancer Drug Des., 1995, 10, 607.
108. B., Dougherty, T. J., Bernacki, R. J. Invest. New Drugs, 1999, 17, 121.
109. Barvian, M. R., Panek, R. L., Lu, G. H., Kraker, A. J., Amar, A., Hartl, B., Hamby, J. M., Showalter, H. D. H. Bioorg. Med. Chem. Lett., 1997, 7, 2903.
110. Gordeladze, J. O., Reseland, J. E. and Drevon, C. A. Curr. Pharm. Des., 2001, 7(4), 275-90.
111. Metcalf, C. A. 3rd, van Schravendijk, M. R., Dalgarno, D. C. and Sawyer, T. K. Curr. Pharm. Des., 2002, 8(23), 2049-75.
112. Woolfrey, J. R. and Weston, G. S. Curr. Pharm. Des., 2002, 8(17), 1527-45.